April 16, 2020
The immunosuppressant tocilizumab may be a promising option for myeloma patients with COVID-19, a case study from China suggests. Dr Changcheng Zheng, MD, of the University of Science and Technology of China and colleagues detailed the case of a 60-year-old man with multiple myeloma who was hospitalised with chest tightness and shortness of breath and subsequently...
Continue Reading

Floor 7, 90 The Terrace
Wellington Central
New Zealand